Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 39, 2019 - Issue 4
Submit an article Journal homepage
250
Views
10
CrossRef citations to date
0
Altmetric
Original Article

The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer

M. L. AlabdullahAcademic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, UK; ;Paediatric Surgery Department, Birmingham Children’s Hospital NHS Trust, Birmingham, UK; Correspondence[email protected]
,
D. A. AhmadDepartment of Histopathology, Division of Cancer and Stem cells, School of Medicine, University of Nottingham, Nottingham, UK;
,
P MoseleyDepartment of Oncology, Nottingham University Hospital, Nottingham, UK;
,
S. MadhusudanDepartment of Oncology, Nottingham University Hospital, Nottingham, UK; ;Translational Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, UK
,
S ChanDepartment of Oncology, Nottingham University Hospital, Nottingham, UK;
&
E. RakhaDepartment of Histopathology, Division of Cancer and Stem cells, School of Medicine, University of Nottingham, Nottingham, UK;
Pages 522-528 | Published online: 04 Feb 2019

References

  • Albasri A, Seth R, Jackson D, Benhasouna A, Crook S, Nateri AS, et al. 2009. C-terminal Tensin-like (CTEN) is an oncogene which alters cell motility possibly through repression of E-cadherin in colorectal cancer. The Journal of Pathology 218:57–65.
  • Altomare DA, Wang HQ, Skele KL, Rienzo AD, Klein-Szanto AJ, Godwin AK, et al. 2004. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23:5853–5857.
  • Bachmann RA, Kim J-H, Wu A-L, Park I-H, Chen J. 2006. A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. Journal of Biological Chemistry 281:7357–7363.
  • Bjornsti M-A, Houghton PJ. 2004. The tor pathway: a target for cancer therapy. Nature Reviews Cancer 4:335–348.
  • Camilleri-Broet S. 2004. HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group. Annals of Oncology Oxford University Press 15:104–112.
  • Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, et al. 2006. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer 107:1801–1811.
  • Fruman DA, Rommel C. 2014. PI3K and cancer: lessons, challenges and opportunities. Nature Reviews Drug Discovery 13:140–156.
  • Heberle AM, Prentzell MT, van Eunen K, Bakker BM, Grellscheid SN, Thedieck K, et al. 2015. Molecular mechanisms of mTOR regulation by stress. Molecular and Cellular Oncology. Taylor and Francis 2:e970489.
  • Herberger B, Puhalla H, Lehnert M, Wrba F, Novak S, Brandstetter A, et al. 2007. Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma. Clinical Cancer Research 13:4795–4799.
  • Hsu C-Y. 2004. Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clinical Cancer Research 10:6432–6436.
  • Huynh H, Teo CCM, Soo KC. 2007. Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. Molecular Cancer Therapeutics 6:2959–2966.
  • Jastrzebski K, Hannan KM, Tchoubrieva EB, Hannan RD, Pearson RB. 2007. Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function. Growth Factors 25:209–226.
  • Kononen J, Bubendorf L, Kallionimeni A, Bärlund M, Schraml P, Leighton S, et al. 1998. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Medicine 4:844–847. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9662379 [cited 2017 November 22].
  • Lynch M, Fitzgerald C, Johnston KA, Wang S, Schmidt EV. 2004. Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. Journal of Biological Chemistry 279:3327–3339.
  • Mamane Y, Petroulakis E, Rong L, Yoshida K, Ler LW, Sonenberg N, et al. 2004. eIF4E – from translation to transformation. Oncogene. 23:3172–3179.
  • Molinolo AA, Hewitt SM, Amornphimoltham P, Keelawat S, Rangdaeng S, Meneses Garcia A, et al. 2007. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clinical Cancer Research 13:4964–4973.
  • No JH, Jeon Y-T, Park I-A, Kim Y-B, Kim JW, Park N-H, et al. 2011. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. Gynecologic Oncology 121:8–12.
  • Rojo F, Najera L, Lirola J, Jimenez J, Guzman M, Sabadell MD, et al. 2007. 4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis. Clinical Cancer Research 13:81–89.
  • Siegel RL, Miller KD, Jemal A. 2016. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians 66:7–30.
  • Vaughan S, Coward JI, Bast RC, Berchuck A, Berek JS, Brenton JD, et al. 2011. Rethinking ovarian cancer: recommendations for improving outcomes. Nature Reviews Cancer 11:719–725.
  • Xiao L, Wang YC, Li WS, Du Y. 2009. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. Journal of Experimental and Clinical Cancer Research 28:152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.